Kamilia Abdelraouf, PhD

Associate Director
Hartford Hospital
Hartofrd, CT, United States

Kamilia Abdelraouf, PhD serves as Associate Director for the Center for Anti-Infective Research and Development at Hartford Hospital in Hartford, Connecticut. She has broad experience in examining the pharmacokinetic and pharmacodynamic profiles of investigational agents as well as PK/PD modeling and simulations. Her research activities involve a wide range of preclinical drug development studies to assess the in vitro and in vivo activity of antibacterial agents, most prominently, the establishment and refinement of animal models of infection. She designs human-simulated regimens of antibacterial agents in murine infection models to assess efficacy at clinically achievable exposures, which improves the translational application of the outcomes from pre-clinical studies into clinical practice.

Dr. Abdelraouf received a Bachelor of Science in Pharmaceutical Sciences from Alexandria University, Egypt in 2004 and a PhD in Pharmaceutics from University of Houston in 2012. She completed a fellowship in Infectious Diseases at Hartford Hospital.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1650 - Efficacy of β-Lactam Therapy against Infections Caused by Metallo-β-lactamase (MBL)-Producing Enterobacterales: Bridging the Susceptibility Testing Gap

  Saturday, October 22, 2022
  10:45 AM – 11:00 AM US ET

• 1652 - Sulbactam against Acinetobacter baumannii Pneumonia: Pharmacokinetic/Pharmacodynamic Appraisal of Current Dosing Recommendations

  Saturday, October 22, 2022
  11:15 AM – 11:30 AM US ET